Metabolites of Serc and Interaction of Serc with Antihistamines

References

• Allison R. D., Barnes R. M. The role of betahistine hydrochloride (Serc) in the treatment of peripheral vascular arterial disease. Angiology 1972, (in press)
   Google Scholar
• Anderson W. D., Kubicek W. G. Effects of betahistine HCl, nicotinic acid, and histamine on basilar blood flow in anesthetized dogs. Stroke 1971; 2: 409
   PubMed Web of Science ®Google Scholar
• Ariëns E. J., Simonis A. M. Autonomic drugs and their receptors. Arch Int Pharmacodyn 1960; 128: 479
   Google Scholar
• Baez S. (1969) Antagonistic effects of histamine and betahistine on the vasoconstrictor actions of catecholamines in mesentery microvessels. Proceedings of 5th European Conference on Microcirculation, Gothenburg, 1968. Karger, Basel/New York
   Google Scholar
• Baez S., Lorenzo L. R., Orkin L. R. Interference by histamine and betahistine HCl with hydrocortisone potentiation of responses to epinephrine, norepinephrine and methoxamine in single smooth muscle cells in situ. Physiologist 1970; 13: 140
   Google Scholar
• Bowman F. J., Bowman E. R., McKennis H., Jr. Studies on the oxidative degradation of betahistine (Sere) in the rabbit. Virginia J Sci 1970a; 21: 143
   Google Scholar
• Bowman F. J., Bowman E. R., McKennis H., Jr. Metabolic conversion of betahistine to 2-pyridylacetic acid in the rabbit. Pharmacologist 1970b; 12: 220
   Google Scholar
• Burkin A. Betahistine treatment of Ménière's syndrome. Clin Med 1967; 74: 41
   Google Scholar
• Burns J., Duncan W. A. M., Scales B. Absorption, distribution and metabolism of the anthelmintic methyridine. Biochem Pharmacol 1967; 16: 463
   PubMedGoogle Scholar
• Edmunds S. L. Treatment for episodic vertigo and Ménière's disease. Eye Ear Nose Throat Monthly 1968; 47: 84
   Google Scholar
• Elia J. C. Cerebral circulation: its relationship to headache and dizziness. Angiology 1965a; 16: 226
   PubMedGoogle Scholar
• Elia J. C. A new approach to the treatment of vertigo associated with Ménière's disease. Angiology 1965b; 16: 464
   PubMedGoogle Scholar
• Elia J. C. Double-blind evaluation of a new treatment for Ménière's syndrome. JAMA 1966a; 196: 187
   PubMed Web of Science ®Google Scholar
• Elia J. C. Microcirculation and Ménière's disease. Rocky Mountain Med J 1966b; 63: 38
   PubMedGoogle Scholar
• Elia J. C. Otogenic vertigo—an occupational hazard. Industr Med Surg 1967; 36: 735, 738, 739
   PubMedGoogle Scholar
• Elia J. C. Long-term treatment of Ménière's disease. Int Surg 1970; 53: 24
   PubMedGoogle Scholar
• Godlowski Z. Pathogenesis and management of Ménière's syndrome in terms of microcirculation. Angiology 1965; 16: 644
   PubMedGoogle Scholar
• Guay R. M. Ménière's disease: Preliminary report of a new treatment. Appl Ther 1970; 12(8)25
   PubMedGoogle Scholar
• Haddy F. J. Effects of histamine on small and large vessel pressures in the dog foreleg. Amer J Physiol 1960; 198: 161
   PubMedGoogle Scholar
• Hartung W. H. Epinephrine and related compounds: influence of structure on physiological activity. Chem Rev 1931; 9: 389
   Google Scholar
• Hicks J. J., Hicks J. N., Cooley H. N. Review of the present status of Ménière's disease. J Med Ass Alabama 1967a; 37: 553
   Google Scholar
• Hicks J. J., Hicks J. N., Cooley H. N. Ménière's disease. Arch Otolaryng (Chic.) 1967b; 86: 610
   PubMedGoogle Scholar
• Horton B. T., Macy D., Jr. Treatment of headache. Med Clin N Amer 1946; 17: 1
   Google Scholar
• Horton B. T. Histaminic cephalgia (Horton's headache or syndrome). Maryland Med J 1961; 10: 178
   Google Scholar
• Horton B. T., Von Leden H. Clinical use of beta-2-pyridylalkylamines. Part I. Mayo Clin Proc 1962; 37: 692
   PubMed Web of Science ®Google Scholar
• Horton B. T. Clinical use of beta-2-pyridyl-alkylamines. Part II. Treatment of histamine cephalgia (Horton's headache), with a note on angina pectoris. Mayo Clin Proc 1962; 37: 713
   PubMed Web of Science ®Google Scholar
• Hunt W. H., Fossbinder R. J. A study of some beta-2 and 4, pyridylalkylamines. J Pharmacol Exp Ther 1942; 75: 299
   Google Scholar
• Konzett H., Bost R. G. On the vasodilator effect of betahistine (Sere) and related substances in the perfused forelimb of the dog. Virginia J Sci 1970; 21: 146
   Google Scholar
• Konzett H., Bost R. G., Bowman F. J., Bowman E. R., McKennis H., Jr. Betahistine, its metabolites, and vascular responses in the fore-limb of the dog. J Pharmacol Exp Ther 1971; 178: 122
   PubMedGoogle Scholar
• LePere D. M. Evaluation of a ney symptomatic treatment for Ménière's disease. Clin Med 1967; 74: 63
   Google Scholar
• Löffler K. Derivate des α-picolyl- und α-picolylmethyl-alkins. Ber Deutsch Chem Ges 1904; 37: 161
   Google Scholar
• Martinez D. M. The effect of Sere (betahistine hydrochloride) on the circulation of the inner ear. Acta Otolaryng (Stockh.) 1972, Suppl. 305
   Google Scholar
• Martins J. K. New basis for control of Ménière's disease. Eye Ear Nose Throat Digest 1968; 30: 47
   Google Scholar
• Martins J. K. Long-term-office treatment of Ménière's disease. Eye Ear Nose Throat Monthly 1969; 48: 410
   PubMedGoogle Scholar
• McKennis H., Jr, Turnbull Bowman L.B.E. R. N-methylation of nicotine and cotinine in vivo. J Biol Chem 1963; 238: 719
   PubMed Web of Science ®Google Scholar
• McKennis H., Jr, Turnbull Bowman L.B.E. R. Additional routes in the metabolism of 3-acetylpyridine. J Biol Chem 1964; 239: 1215
   PubMedGoogle Scholar
• Schayer R. W. Induced synthesis of histamine, microcirculatory regulation and the mechanism of the action of the adrenal glucocorticoid hormones. Progr Allerg 1963; 7: 187
   PubMedGoogle Scholar
• Seipel J. H. A rheoencephalographic study of the effect of betahistine hydrochloride on the normal human cerebral and scalp circulations. Fed Proc 1971; 30: 274
   Google Scholar
• Stough A. R. A tolerance study of betahistine dihydrochloride. Curr Ther Res 1963; 5: 542
   PubMedGoogle Scholar
• Suga F., Snow J. B. Cochlear blood flow in response to vasodilating drugs and some related agents. Laryngoscope 1969; 79: 1956
   PubMed Web of Science ®Google Scholar
• Walter L. A., Hunt W. H., Fossbinder R. J. Beta-(2- and 4-pyridylalkyl)-amines. J Amer Chem Soc 1941; 63: 2771
   Google Scholar
• Werle E., Palm D. Pyridylalkylamine und diamoxydose. Biochem Z 1953; 323: 424
   PubMedGoogle Scholar
• Wolfson R. J., Myers D., Schlosser W. D. Ménière's disease—treatment with betahistine hydrochloride. Eye Ear Nose Throat Monthly 1967; 46: 891
   Google Scholar